The Manufacturers Life Insurance Company Increases Holdings in Abercrombie & Fitch Company $ANF

Key Points

• The Manufacturers Life Insurance Company increased its stake in Abercrombie & Fitch by 56.3%, owning approximately 371,871 shares valued at $28.4 million.
• Abercrombie & Fitch reported $2.32 earnings per share for the last quarter, beating analysts' expectations and showing a 6.6% year-over-year revenue increase.
• Several analysts have given Abercrombie & Fitch a consensus rating of "Moderate Buy", with an average target price of $115.25.

The Manufacturers Life Insurance Company boosted its holdings in Abercrombie & Fitch Company (NYSE:ANF - Free Report) by 56.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 371,871 shares of the apparel retailer's stock after acquiring an additional 133,989 shares during the quarter. The Manufacturers Life Insurance Company owned 0.78% of Abercrombie & Fitch worth $28,400,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of ANF. American Century Companies Inc. increased its stake in shares of Abercrombie & Fitch by 18.5% during the 1st quarter. American Century Companies Inc. now owns 806,980 shares of the apparel retailer's stock worth $61,629,000 after purchasing an additional 126,050 shares during the last quarter. Assenagon Asset Management S.A. purchased a new position in Abercrombie & Fitch in the first quarter worth $56,569,000. Jupiter Asset Management Ltd. boosted its position in Abercrombie & Fitch by 0.8% during the first quarter. Jupiter Asset Management Ltd. now owns 621,234 shares of the apparel retailer's stock valued at $47,444,000 after buying an additional 5,006 shares during the period. Nuveen Asset Management LLC boosted its position in Abercrombie & Fitch by 6.4% during the fourth quarter. Nuveen Asset Management LLC now owns 552,374 shares of the apparel retailer's stock valued at $82,563,000 after buying an additional 33,309 shares during the period. Finally, Price T Rowe Associates Inc. MD boosted its position in Abercrombie & Fitch by 5.5% during the first quarter. Price T Rowe Associates Inc. MD now owns 549,081 shares of the apparel retailer's stock valued at $41,934,000 after buying an additional 28,379 shares during the period.

Abercrombie & Fitch Stock Performance

Shares of ANF traded up $1.80 on Friday, hitting $95.28. 1,661,672 shares of the stock traded hands, compared to its average volume of 2,101,159. Abercrombie & Fitch Company has a one year low of $65.40 and a one year high of $167.71. The business has a 50 day simple moving average of $94.46 and a 200 day simple moving average of $84.40. The company has a market capitalization of $4.54 billion, a PE ratio of 9.01 and a beta of 1.44.

Abercrombie & Fitch (NYSE:ANF - Get Free Report) last issued its earnings results on Wednesday, August 27th. The apparel retailer reported $2.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.27 by $0.05. Abercrombie & Fitch had a net margin of 10.61% and a return on equity of 40.02%. The company had revenue of $1.21 billion for the quarter, compared to analysts' expectations of $1.19 billion. During the same quarter last year, the company posted $2.50 earnings per share. The firm's quarterly revenue was up 6.6% on a year-over-year basis. Abercrombie & Fitch has set its FY 2025 guidance at 10.000-10.500 EPS. Q3 2025 guidance at 2.050-2.250 EPS. On average, equities analysts expect that Abercrombie & Fitch Company will post 10.62 earnings per share for the current year.

Insider Buying and Selling at Abercrombie & Fitch

In other news, Director James A. Goldman sold 5,072 shares of Abercrombie & Fitch stock in a transaction on Friday, August 29th. The shares were sold at an average price of $96.18, for a total transaction of $487,824.96. Following the transaction, the director owned 7,565 shares in the company, valued at $727,601.70. This trade represents a 40.14% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Jay Rust sold 1,500 shares of Abercrombie & Fitch stock in a transaction on Friday, August 29th. The stock was sold at an average price of $93.15, for a total transaction of $139,725.00. Following the transaction, the executive vice president owned 6,648 shares in the company, valued at $619,261.20. This represents a 18.41% decrease in their position. The disclosure for this sale can be found here. Company insiders own 2.29% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Jefferies Financial Group cut their price target on shares of Abercrombie & Fitch from $170.00 to $135.00 and set a "buy" rating for the company in a research report on Wednesday, May 21st. Raymond James Financial set a $105.00 price target on shares of Abercrombie & Fitch and gave the company an "outperform" rating in a research report on Thursday, August 28th. Citigroup restated a "neutral" rating and set a $105.00 price target on shares of Abercrombie & Fitch in a research report on Wednesday, August 20th. UBS Group reiterated a "buy" rating on shares of Abercrombie & Fitch in a report on Wednesday, May 28th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Abercrombie & Fitch from $151.00 to $145.00 and set an "overweight" rating for the company in a report on Thursday, August 28th. Five investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $115.25.

About Abercrombie & Fitch

Abercrombie & Fitch Co engages in the retail of apparel, personal care products, and accessories. The firm operates through following geographical segments: Americas, EMEA and APAC. The Americas segment includes operations in North America and South America. The EMEA segment includes operations in Europe, the Middle East and Africa.